1995
Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: Results of thrombolysis in myocardial infarction (TIMI) phase II study
Zaret B, Wackers F, Terrin M, Forman S, Williams D, Knatterud G, Braunwald E, Group F. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: Results of thrombolysis in myocardial infarction (TIMI) phase II study. Journal Of The American College Of Cardiology 1995, 26: 73-79. PMID: 7797778, DOI: 10.1016/0735-1097(95)00146-q.Peer-Reviewed Original ResearchConceptsLeft ventricular ejection fractionVentricular ejection fractionExercise left ventricular ejection fractionPeak exercise ejection fractionExercise ejection fractionEjection fractionAcute myocardial infarctionImportant prognostic indexThrombolytic therapyPrethrombolytic eraCardiac mortalityPrognostic indexPrognostic valueMyocardial infarctionMortality rateMyocardial Infarction Phase II (TIMI II) studyMyocardial Infarction trialRest ejection fractionSubmaximal supine exercisePhase II studySurvival of patientsResults of thrombolysisHigh mortality rateCause mortalityII study
1989
Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot study
Rogers W, Bourge R, Papapietro S, Wackers F, Zaret B, Forman S, Dodge H, Robertson T, Passamani E, Braunwald E, Investigators F. Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot study. The American Journal Of Cardiology 1989, 63: 503-512. PMID: 2521976, DOI: 10.1016/0002-9149(89)90889-8.Peer-Reviewed Original ResearchConceptsAcute myocardial infarctionGood functional outcomeAngioplasty groupEjection fractionPeak exerciseHospital dischargeFunctional outcomePilot studyMyocardial Infarction Phase II (TIMI II) studyIntravenous recombinant tissue plasminogen activatorLeft ventricular ejection fractionPhase II pilot studyRecombinant tissue plasminogen activatorPhase II studyGood ventricular functionHours of onsetPercutaneous transluminal angioplastyRt-PA infusionVentricular ejection fractionObservational pilot studyST-segment elevationEquilibrium radionuclide ventriculographyGated equilibrium radionuclide ventriculographyAbsence of arrhythmiasTissue plasminogen activator